Exploring United States Antimony Corporation (UAMY) Investor Profile: Who’s Buying and Why?

You've seen the stock price of United States Antimony Corporation (UAMY) surge-its market capitalization has ballooned to over $852 million in late 2025, a massive leap that demands a closer look at who is buying and why they're suddenly interested in a niche critical minerals producer.

Is this a retail-driven frenzy, or is serious institutional money moving in? The data is clear: while individual investors still hold a large portion-about 77.85%-institutional ownership is accelerating, with the number of funds reporting positions jumping by over 64% in the last quarter alone, accumulating 42,140K shares.

But what's the anchor for this conviction, especially when Q3 2025 reported an earnings per share (EPS) loss of ($0.04)? It's the strategic shift: the company secured a five-year, $245 million Defense Logistics Agency (DLA) contract, plus a $107 million commercial deal, giving them a clear $352 million revenue pipeline that dwarfs the full-year 2025 revenue guidance of $40 million-$50 million.

This is defintely a bet on the critical mineral supply chain, not just near-term profit, so what does the Vanguard Group Inc. or BlackRock, Inc. see in UAMY that others might miss?

Who Invests in United States Antimony Corporation (UAMY) and Why?

The investor base for United States Antimony Corporation (UAMY) is a fascinating mix, dominated by the retail crowd but seeing a sharp, strategic increase from institutional players who are chasing the critical mineral supply story. The core takeaway is simple: this is a growth-and-security play, not an income stock.

As of late 2025, the stock's ownership structure is heavily weighted toward individual investors, or the retail float. While institutional ownership has been accumulating, it remains relatively low for a company with a market capitalization that has soared to approximately $1.1 billion. Recent filings show institutional ownership hovering around 28.22% to 35.04% of total shares, a significant jump from prior periods, but it still leaves a large portion-around 77.85% of the public float-in the hands of individual investors and public companies. This high retail concentration often means higher volatility, so be defintely aware of that.

The institutional money that is moving in is serious. I'm talking about firms like BlackRock, Inc., Vanguard Group Inc., State Street Corp, and hedge funds such as Citadel Advisors Llc. These are not passive investors; they are making a calculated bet on the company's strategic shift. For a deeper dive into the company's foundation, you can check out United States Antimony Corporation (UAMY): History, Ownership, Mission, How It Works & Makes Money.

The Investment Motivation: Growth and National Security

Investors are buying United States Antimony Corporation (UAMY) for two main reasons: explosive near-term growth and its unique position as a domestic critical mineral supplier. The company is the only vertically integrated antimony producer outside of China, which is a massive strategic advantage given China's recent export restrictions on critical metals.

The numbers from the 2025 fiscal year tell the story better than any adjective. The company is in a rapid scaling phase, fueled by major contracts. For the first nine months of 2025, revenues jumped 182% year-over-year to $26.23 million. Management has narrowed its full fiscal year 2025 revenue guidance to between $40 million and $43 million, and the 2026 revenue projection is a staggering $125 million. That's the kind of growth that attracts serious capital.

Here's the quick math on the strategic opportunity: The company secured a five-year, up to $245 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the U.S. Defense Logistics Agency (DLA) for domestically sourced metallic antimony. Antimony is essential for defense applications like ammunition and sensors, making this a critical national security play. This is a massive revenue pipeline-more than 20 times the prior year's sales base.

• Antimony is a U.S. critical mineral.
• $245 million DLA contract is a game-changer.
• 2025 revenue guidance: $40M - $43M.

Investment Strategies in Play

The dominant strategy here is clearly Growth Investing, often with a speculative bent given the high-risk, high-reward nature of mining and the reliance on a few large contracts. Investors are betting on the successful execution of the Montana refinery expansion, which aims to increase throughput capacity by more than six times the current rate.

However, the investor profile is nuanced. You see a clear mix of strategies:

The presence of significant insider buying, like the CEO's purchase, is a classic signal for value investors, suggesting management believes the stock is undervalued relative to the company's future cash flow potential from its new contracts. What this estimate hides, though, is the execution risk; scaling up production from roughly 100 tons per month to 500-600 tons is a massive operational lift that can get bumpy.

Institutional Ownership and Major Shareholders of United States Antimony Corporation (UAMY)

If you're looking at United States Antimony Corporation (UAMY), the main takeaway is simple: big money has been moving in fast, shifting the investor profile from a small-cap play to a stock with significant institutional backing, driven by the critical minerals trend.

The institutional ownership-meaning mutual funds, pension funds, hedge funds, and other professional money managers-has surged to approximately 35.04% of the total shares outstanding as of the end of the third quarter of 2025. This is a dramatic transformation, considering management noted institutional ownership was near zero just 1.5 years ago, and now it sits at roughly 30% of the public float.

Top Institutional Investors: Who is Buying UAMY?

The list of major holders is dominated by the world's largest asset managers, which is a strong signal of increasing legitimacy and liquidity for United States Antimony Corporation. These firms are buying UAMY not just for speculation, but often for inclusion in their broad-market index funds, like the Russell 2000 ETF, or thematic funds focused on materials and defense.

Here's a quick look at the top institutional holders based on their Q3 2025 13F filings (as of September 30, 2025), showing the value of their stakes in thousands of US dollars:

BlackRock and Vanguard Group Inc. alone represent a significant chunk of the institutional ownership, which is typical for companies included in major exchange-traded funds (ETFs) and mutual funds. The presence of firms like Citadel Advisors Llc, a major hedge fund, also suggests a more active, trading-oriented interest alongside the passive index funds.

Recent Shifts: The Accumulation Story

The most compelling part of the UAMY investor profile is the recent accumulation. In the third quarter of 2025 alone, 113 institutions increased their positions, adding a net total of 22,776,875 shares. That's a strong vote of confidence.

• State Street Corp's massive increase: This firm added an astounding 4,763,799 shares, representing a 428.787% increase in its stake in Q3 2025.
• New Entrants: Driehaus Capital Management Llc and Segall Bryant & Hamill, Llc were major new buyers, establishing positions of 2,822,038 shares and 2,481,275 shares, respectively.
• Notable Reduction: Not everyone is buying; Morgan Stanley, for instance, removed 1,480,149 shares, cutting its position by over 60%.

This tells you the story is one of rapid accumulation, but with some profit-taking or reallocation happening on the edges. The net flow is overwhelmingly positive, however.

Impact on Stock Price and Strategy: Why They're Buying

Institutional investors aren't just passive holders; their participation fundamentally changes a company's trajectory and stock stability. For United States Antimony Corporation, the influx is directly tied to its strategic pivot into the critical minerals supply chain, especially antimony, which is vital for defense and flame retardants.

Here's the quick math: UAMY's management is guiding for 2025 fiscal year revenue between $40 million and $50 million, a significant jump from prior years. The institutional buying is essentially a bet on this growth, fueled by geopolitical risks and government interest in securing domestic supply.

• Strategic Validation: A $25 million direct offering in October 2025 was led by a major long-only mutual fund, signaling that sophisticated capital is backing the company's expansion plans, which include increasing capacity at the Madero Smelter and expanding mineral leaseholds.
• Defense Contract Confidence: The company secured a substantial $245 million contract with the Defense Logistics Agency, a clear catalyst for institutional interest, as it validates UAMY's role in U.S. national security.
• Liquidity and Stability: High institutional ownership typically reduces volatility and provides a stable base of demand for the stock. When BlackRock or Vanguard are in, they tend to stay for the long haul, which is defintely a good sign for long-term investors.

The institutional confidence is a clear indicator that the market views UAMY as a key player in the domestic critical minerals supply chain, which is a macro-economic trend much bigger than the company itself. For more on the company's background, you can check out United States Antimony Corporation (UAMY): History, Ownership, Mission, How It Works & Makes Money.

Key Investors and Their Impact on United States Antimony Corporation (UAMY)

If you're looking at United States Antimony Corporation (UAMY), the investor profile tells a clear story: sophisticated capital is moving in, but retail investors still hold the majority stake. The shift is toward greater institutional confidence, fueled by the company's critical mineral focus.

As of late 2025, institutional investors hold over 42 million shares, representing a significant accumulation trend. That's a massive increase of 42.22% in total institutional shares owned in the last three months alone, showing a clear vote of confidence in the company's strategic pivot toward domestic supply chain resilience. To be fair, retail investors still own the lion's share, but the quality of the new institutional money is what matters most here.

The Institutional Heavyweights: Who's Accumulating?

The largest shareholders are not small-time players; they are the behemoths of the asset management world, the ones who move markets. These institutions are primarily passive funds and large asset managers, which suggests a belief in the long-term, index-driven growth of the critical minerals sector, where antimony plays a key role.

Here's a quick look at the top institutional holders as of the third quarter ending September 30, 2025:

The most telling move is State Street Corp's massive increase of over 428% in their position. When a major index fund manager like State Street or Vanguard Group Inc significantly raises its stake, it's often a sign that United States Antimony Corporation (UAMY) is becoming a more substantial component in the indices they track, or that they are increasing their exposure to the critical minerals theme. It's defintely a strong signal of growing index inclusion.

Insider Alignment and Recent Capital Influx

Beyond the institutions, the company's insider activity is a crucial signal. CEO Gary C. Evans, a major individual shareholder, recently purchased 100,000 shares in September 2025 for a total transaction value of $613,000.00. This move, which increased his total holdings to over 2.37 million shares, shows strong management alignment with shareholder interests. When the CEO puts their own money on the line, it's a powerful endorsement.

This insider confidence maps directly to the company's ability to raise capital. In October 2025, United States Antimony Corporation (UAMY) completed a $25 million registered direct offering with institutional investors. This was part of a larger total of $69.25 million raised across three recent rounds. The fact that the company could execute these offerings at minimal or no discount to the market price is a clear indicator of strong fundamental investor interest. Breaking Down United States Antimony Corporation (UAMY) Financial Health: Key Insights for Investors will show you how this capital is being deployed.

Investor Influence: Funding the Growth Engine

The influence of these investors is less about activism and more about enabling strategic growth. Their capital is directly funding the company's expansion, which is critical for a mining and processing operation. Here's the quick math: the $69.25 million in recent capital raises is being used to fuel specific, high-impact projects:

• Acquire additional antimony and critical mineral inventory.
• Expand mineral leaseholds in Alaska and Montana.
• Increase capacity at the Madero Smelter in Mexico.
• Fund the $5 million acquisition of a tungsten mining operation in Canada.

This institutional money is essentially the rocket fuel for the company's strategic vision-to become a dominant, fully integrated antimony producer outside of China. Their participation in direct offerings, particularly those priced above market, demonstrates that they are willing to pay a premium to secure a stake in a company that management is guiding toward a fiscal year 2025 revenue guidance of $40 million to $50 million.

Market Impact and Investor Sentiment

You're looking at United States Antimony Corporation (UAMY) and wondering who's buying and why the stock is so volatile. The short answer is that institutional money is pouring in, driving a bullish sentiment, but the market is still reacting sharply to earnings misses. This is a story of long-term strategic confidence clashing with near-term operational hiccups.

Investor sentiment is defintely leaning positive, driven by the company's strategic position in the critical minerals space. The institutional investor count jumped significantly, with 217 funds reporting positions as of the latest quarter, an increase of 64.39% over the prior period. This surge means a lot of smart money is betting on the long-term growth story, especially given the company's focus on becoming a major antimony producer outside of China. Total shares owned by institutions increased by 42.22% to 42,140K shares in the last three months.

The overall market outlook from these sophisticated investors is bullish, which you can see in the put/call ratio (an indicator of market mood). It sits at a low 0.28, suggesting that options traders are anticipating price increases rather than declines. For a deeper dive into the company's long-term vision, you should check out the Mission Statement, Vision, & Core Values of United States Antimony Corporation (UAMY).

Who's Buying: The Institutional Shift

The biggest players are making their moves, and the flow of capital shows a clear accumulation trend. Looking at the latest filings from Q3 2025, major firms are building substantial positions in United States Antimony Corporation (UAMY). This isn't just passive index investing; some of the increases are massive, showing conviction.

For example, State Street Corp added a colossal 4,763,799 shares in Q3 2025, a jump of over 428.8% in their stake. Citadel Advisors Llc also piled in, increasing their holding by 1,978,834 shares, a 148.5% increase. These are not small, speculative trades. Still, not everyone is a buyer; Morgan Stanley removed 1,480,149 shares (-60.7%) in the same quarter, showing a divergence in opinion on the near-term risk profile.

Here's a quick snapshot of the largest institutional holders as of September 30, 2025:

• BlackRock, Inc.: 7,223,854 shares
• State Street Corp: 5,874,792 shares
• Vanguard Group Inc: 5,597,951 shares
• Citadel Advisors Llc: 3,311,701 shares

Plus, insider confidence is a factor. CEO Gary C. Evans bought 100,000 shares at $6.13 on November 20, 2025, a modest but clear signal that management sees value at current prices. You always want to see the people running the show putting their own money in.

Market Reactions to Key Events

The stock price of United States Antimony Corporation (UAMY) has been a roller coaster, reacting violently to both good news and bad, which is typical for a growth-focused company in a cyclical industry. The stock closed at $5.87 on November 21, 2025, having fallen in the days following the Q3 earnings.

Here's the quick math on recent market moves:

• Q3 2025 Earnings Miss (Nov 12, 2025): The stock dropped 5.58% to $8.07 after the company reported an EPS of -$0.04 against a forecasted $0.03. Revenue also missed, coming in at $8.7 million versus a $12.8 million forecast.
• Major Supply Contract (Nov 14, 2025): Shares immediately trended up by 7.71% following the announcement of a nearly $107M supply agreement for antimony trioxide with a U.S. industrial fabric manufacturer. This news signaled strong future revenue.
• Capital Raise (Oct 2025): The stock surged 10% in early trading after United States Antimony Corporation (UAMY) announced a $26.25M direct offering to institutional investors to finance procurements and smelting enhancements.

The key takeaway is that the market punishes short-term misses but rewards strategic moves that shore up the long-term supply chain and revenue base.

Analyst Consensus and Price Targets

Analyst perspectives on United States Antimony Corporation (UAMY) are overwhelmingly positive, despite the recent earnings volatility. The consensus rating across multiple firms is either a 'Strong Buy' or 'Buy,' with 75.00% of analysts recommending a Buy rating.

The average consensus price target is $6.08 as of November 20, 2025, but this figure is skewed by older, lower targets. The most recent and aggressive target comes from HC Wainwright & Co., which lifted its price objective from $8.50 to $10.25 on November 13, 2025. This implies a significant upside from the current stock price, reflecting confidence in the company's ability to capitalize on its new contracts and production capacity expansions.

The projected annual non-GAAP Earnings Per Share (EPS) for the 2025 fiscal year is $0.06. This positive full-year outlook, despite the Q3 loss, is why analysts and institutions are looking past the short-term noise. They are focused on the expected capacity increase to 500-600 tons of antimony per month and the large contracts, like the $245 million deal with the Defense Logistics Agency.

The key investor action here is to align your time horizon with the institutional view: focus on the long-term strategic value, not the daily price fluctuations. Your next step should be to model the impact of the $107M supply agreement on the 2026 revenue guidance of $125 million.